The stakes are high in the area of COVID-19 vaccine research with many nations wanting to be the first to create an effective vaccine. Recent prosecutions against Chinese state-sponsored hackers and the Russian APT29 accusations show the lengths that nations will go to in order to gain an advantage.
Australian research progresses apace, with the latest prediction being that a vaccine will be ready towards the end of the year.
Zero trust is the recommended way to protect healthcare networks because it offers the highest degree of separation, making internal proliferation or propagation of malware almost impossible, and preventing hackers from jumping from machine to machine.
Zero trust is exactly that – while in ordinary networks computers are divided into zones, and each machine in a zone can directly connect to another, in zero trust networks connections are authenticated and then authorised.
Unisys and Stealth
Agilient partners with Unisys to provide a zero trust networking solution called Stealth. Developed for the US military, Stealth operates on a huge variety of platforms and, when combined with Stealth ID secure dynamic biometric authentication, provides a robust network very difficult to penetrate. This network operates effectively across different sites including in the office, at home or on the road.
Health organisations, especially those working on COVID-19 vaccine research, are highly encouraged to talk with Agilient’s expert consultants about how to protect their research and IT environments in general.
Contact us today for a confidential discussion.
Author: David Steele, Agilient Consultant